AzTrials
AzTrials

HemodialysisDIALAPANCT07118007

Assessment of the Benefits of Adapted Physical Activity in Pediatric Hemodialysis Patients

A study testing adapted physical activity in people with Hemodialysis, run by Hospices Civils de Lyon.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Children, adolescents, and young adults undergoing pediatric hemodialysis often experience functional limitations in daily life. Their level of physical activity is generally lower than that of healthy peers of the same age, due to the lack of sports programs adapted both to their medical conditions and to the… Read more about this study

Who is it for?
Ages 5 to 20 years
Conditions the study is for
Hemodialysis
What is being tested?
adapted physical activity
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
No sites listed yet
Study dates
1 Oct 2025to 1 Mar 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 20 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • Patient requiring hemodialysis sessions for end-stage renal disease
  • Patient aged between 5 and 20 years
  • Patient followed in the pediatric nephrology department at hospital Lyon (HFME : Hôpital Femme Mère Enfant)
  • Adult patient or parents/legal guardians informed about the study and having provided written consent for participation
  • Patient covered by a social security

Who cannot join

  • Medical or surgical contraindications to adapted physical activity.
  • Persons deprived of liberty by judicial or administrative decision.
  • Persons undergoing psychiatric care.
  • Persons admitted to a healthcare or social facility for reasons other than research participation.
  • Adults under legal protection measures (curators)
  • Persons not affiliated with a social security scheme or beneficiaries of a similar system
  • Pregnant women.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

Official title: Assessment of the Benefits of Adapted Physical Activity in Pediatric Hemodialysis Patients-DIALAPA Study

Children, adolescents, and young adults undergoing pediatric hemodialysis often experience functional limitations in daily life. Their level of physical activity is generally lower than that of healthy peers of the same age, due to the lack of sports programs adapted both to their medical conditions and to the constraints of dialysis (notably, having to remain in bed for several hours, several times a week). These limitations affect not only their cardiovascular function but also their quality of life.

Through the implementation of an Adapted Physical Activity (APA) program for dialysis patients, we aim to assess the potential benefits of this approach on muscle strength, functional abilities, cardiovascular health, and quality of life

Conditions
Hemodialysis
Being tested
adapted physical activity
Keywords
Hemodialysis, physical activity
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • adapted physical activityOther

    adapted physical activity for 30 to 45 minutes twice per week

Study groups in NCT07118007
Study groupRoleWhat they receive
Patient requiring hemodialysis for end-stage renal diseaseOtherPatient requiring hemodialysis for end-stage renal disease aged 5 to 20 years
Receives: Other: adapted physical activity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. mass-to-muscle mass ratio between M0 and M6

    Change in the mass-to-muscle mass ratio between M0 and M6, measured at the end of the hemodialysis session using bioelectrical impedance analysis.

    Measured: Between baseline (M0) and month 6 (M6)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2025
  2. Study start1 Oct 2025 (estimated)
  3. Primary completion1 Mar 2029 (estimated)
  4. Study completion1 Mar 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
15 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07118007
Sponsor's protocol ID
69HCL25_0588
Acronym
DIALAPA
Status last verified
Aug 2025
First submitted
5 Aug 2025
Last updated
12 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing adapted physical activity in people with Hemodialysis, run by Hospices Civils de Lyon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 12 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Melodie MOSCA, MD (04 27 85 67 49 ext. +33, melodie.mosca@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

mass-to-muscle mass ratio between M0 and M6 (time frame: Between baseline (M0) and month 6 (M6)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in